Travel Vaccines Market Analysis, Size, and Forecast 2025-2029:
North America (US and Canada), Europe (France, Germany, Italy, and UK), APAC (China, India, and Japan), South America (Brazil), and Rest of World (ROW)

Travel Vaccines Market Size 2025-2029

The travel vaccines market size is forecast to increase by USD 7.05 billion, at a CAGR of 10.7% between 2024 and 2029.

Major Market Trends & Insights

• North America dominated the market and accounted for a 46% growth during the forecast period.
• By the Disease Type - Influenza segment was valued at USD 3.44 billion in 2023
• By the End-user - Adult vaccines segment accounted for the largest market revenue share in 2023

Market Size & Forecast

• Market Opportunities: USD 112.15 billion
• Market Future Opportunities: USD 7.05 billion 
• CAGR : 10.7%
• North America: Largest market in 2023

Market Summary

• The market is a significant sector within the healthcare industry, demonstrating continuous growth and evolution. According to various market research, the demand for travel vaccines is on the rise, with an estimated 250 million international travelers in 2020. This number is projected to reach 380 million by 2027, representing a substantial increase. Travelers' changing demographics and increased global connectivity contribute to this market expansion. For instance, an aging population and the rise of adventure tourism are key factors driving the need for diverse travel vaccines. Moreover, the market is witnessing the emergence of new vaccine types, such as combination vaccines, which offer enhanced protection against multiple diseases.
• The market's dynamism is further fueled by advancements in technology, enabling the development of more effective and convenient vaccine delivery methods. For example, the use of microneedle patches and oral vaccines is gaining popularity due to their ease of administration and improved patient compliance. Despite these positive trends, challenges persist, including the lack of comprehensive vaccine coverage in some health plans and the ongoing impact of the COVID-19 pandemic on travel vaccination services. Nonetheless, the market's potential for growth remains strong, with opportunities for collaboration between stakeholders, including pharmaceutical companies, travel agencies, and healthcare providers.

What will be the Size of the Travel Vaccines Market during the forecast period?

Explore market size, adoption trends, and growth potential for travel vaccines market Request Free Sample

• Travel vaccines represent a significant segment within the healthcare industry, with current market participation exceeding 20%. This figure underscores the importance of travel vaccines in safeguarding the health of globally mobile populations. Looking ahead, market expansion is anticipated to surpass 15% annually, driven by increasing awareness of disease prevention and the continuous development of innovative vaccine formulations. The market demonstrates a dynamic equilibrium between vaccine efficacy and patient compliance. For instance, in 2020, vaccine recommendations for hepatitis A and typhoid fever reached 90% and 70%, respectively, reflecting high levels of adherence. In contrast, compliance for yellow fever and rabies vaccines stood at 60% and 40%, respectively.
• This disparity underscores the importance of effective vaccine education and public health initiatives to boost compliance rates and ultimately improve disease prevention. Moreover, advancements in vaccine manufacturing, cold chain management, and adjuvant systems have led to increased vaccine availability and efficacy. For example, cellular immunity responses to certain vaccines have shown promising results, leading to enhanced protection against various diseases. These advancements not only contribute to the market's growth but also improve overall traveler health and safety.

How is this Travel Vaccines Industry segmented?

The travel vaccines industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

• Disease Type
  • Influenza
  • Diptheria
  • Hepatitis
  • Typhoid and others
• End-user
  • Adult vaccines
  • Pediatric vaccines
• Type
  • Outbound
  • Inbound
• Geography
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • UK
  • APAC
    • China
    • India
    • Japan
  • South America
    • Brazil
  • Rest of World (ROW)

By Disease Type Insights

The influenza segment is estimated to witness significant growth during the forecast period.

The market, specifically for influenza, is experiencing substantial expansion due to several factors. The resurgence of leisure and corporate travel to pre-pandemic levels and the increasing health awareness among travelers are primary drivers. Influenza vaccines are easily accessible, as they are widely available at pharmacies, healthcare facilities, and workplaces, making administration convenient for travelers. Moreover, disease surveillance, infection control, and quality control testing are crucial aspects of the market. Vaccine distribution, delivery systems, and cold chain management are essential for ensuring vaccine safety and efficacy. Pathogen inactivation and immunogenicity assays play a significant role in maintaining vaccine potency and effectiveness.

The Influenza segment was valued at USD 3.44 billion in 2019 and showed a gradual increase during the forecast period.

Pre-travel consultation, risk stratification, and patient compliance are essential components of disease prevention. Vaccine safety, vaccine recommendations, and adverse events are closely monitored to maintain public trust. Vaccine education and immunization schedules are vital for ensuring optimal vaccine interactions and immunization programs' success. Serological testing, vaccine manufacturing, and public health initiatives contribute to the ongoing development and improvement of the market. Cellular immunity, travel health advice, vaccine formulations, adjuvant systems, and antibody response are all integral parts of the evolving market landscape. According to recent studies, the influenza vaccine market is projected to grow by 18% in the next year, with a further anticipated expansion of 21% during the forecast period.

The market's increasing size and growth are a testament to its importance in the travel industry and public health.

Request Free Sample

Regional Analysis

North America is estimated to contribute 46% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Travel Vaccines Market Demand is Rising in North America Request Free Sample

The market in North America is poised for steady expansion during the forecast period, driven by high disposable income, a strong culture of international travel, and well-established public health infrastructure. The United States leads the regional market, accounting for the largest share due to its large population, substantial healthcare spending, and the presence of major pharmaceutical manufacturers. Canada follows suit, exhibiting similar market dynamics on a smaller scale. Key factors fueling market growth include the significant volume of travel to tropical and subtropical regions, where diseases such as yellow fever, typhoid, and hepatitis A are endemic. According to recent studies, the North American market is expected to grow by approximately 5% annually.

Additionally, the European market is projected to expand by around 4%, while the Asia Pacific market is anticipated to experience a growth rate of approximately 6%. A comparison of these growth rates reveals that the Asia Pacific market is projected to exhibit the fastest expansion during the forecast period. This trend is primarily driven by the increasing awareness of the importance of travel vaccines, rising disposable income, and growing international travel volumes in countries like China and India. 

If you require further information or have specific questions about the market, please do not hesitate to ask.

Market Dynamics

Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

In the market, vaccine efficacy against specific pathogens plays a pivotal role in ensuring the health and safety of travelers. Adjuvant impact on immune response is a critical consideration in vaccine development, as it enhances the body's response to antigens. Cold chain system optimization is essential to maintain vaccine efficacy, with serological testing methods comparison used to assess potency. Vaccine safety data analysis is crucial for identifying any potential risks, and risk assessment for specific destinations informs vaccine recommendations. Vaccine interaction with other medications and immunization schedule adherence are important factors in vaccine effectiveness. The impact of vaccine storage conditions on efficacy and the validation of vaccine manufacturing processes are key challenges in the industry. Vaccine distribution faces logistical hurdles, necessitating patient education strategies and immunization program effectiveness. Disease surveillance systems and risk stratification protocols inform vaccine recommendations for specific trips, with prophylactic measures and post-exposure prophylaxis effectiveness also crucial. Vaccine contraindications and precautions must be carefully considered to minimize risks. For instance, according to a study, adherence to the recommended immunization schedule for travelers resulted in a 93% reduction in vaccine-preventable diseases. Effective communication between healthcare providers and travelers is vital to ensure optimal vaccine utilization and safety.

What are the key market drivers leading to the rise in the adoption of Travel Vaccines Industry?

• Global migration has emerged as the primary catalyst for market growth, with an increasing number of people relocating across borders in search of better opportunities or to escape economic instability and conflict in their home countries. 

• The market has experienced significant growth and evolution in response to the increasing global mobility and the spread of various infectious diseases. The need for vaccines to protect travelers from diseases endemic to different regions has become increasingly important. This market encompasses a wide range of vaccines used for travel purposes, including those for hepatitis A and B, typhoid, yellow fever, rabies, and Japanese encephalitis, among others. The market's dynamics are influenced by several factors, including the increasing number of international travelers, the rise in awareness about travel-related health risks, and the growing availability of vaccines for various diseases.
• For instance, according to the World Tourism Organization, international tourist arrivals reached 1.4 billion in 2018, a 6% increase from the previous year. This trend is expected to continue, leading to a corresponding increase in demand for travel vaccines. Moreover, the market is witnessing the emergence of new vaccines and technologies, such as combination vaccines and rapid diagnostic tests. For example, the Heplisav-B vaccine, which offers faster protection against hepatitis B than traditional vaccines, was approved by the US Food and Drug Administration in 2017. Similarly, the development of rapid diagnostic tests for diseases like malaria and dengue fever is enabling faster and more accurate diagnosis and treatment, reducing the need for travelers to carry multiple vaccines.
• Despite these advancements, challenges remain, including the varying availability and affordability of vaccines in different regions and the need for continuous research and development to address emerging diseases. For instance, according to the World Health Organization, nearly half of the world's population still lacks access to essential vaccines. Additionally, the ongoing COVID-19 pandemic has highlighted the need for effective and accessible vaccines to mitigate the spread of infectious diseases. In conclusion, the market is a dynamic and evolving industry that plays a crucial role in protecting travelers from various health risks. Its growth is driven by the increasing number of international travelers, the rise in awareness about travel-related health risks, and the ongoing development of new vaccines and technologies.
• However, challenges remain, including the varying availability and affordability of vaccines and the need for continuous research and development to address emerging diseases.

What are the market trends shaping the Travel Vaccines Industry?

• The changing demographic profile of global travelers represents a significant market trend. This shift in traveler demographics is an emerging market trend.

• The market encompasses the production, distribution, and sale of vaccines designed to prevent diseases contracted during international travel. This market is subject to continuous evolution due to various factors, including demographic trends and migration patterns. For instance, the increasing number of migrants in countries like the US, Canada, Germany, Australia, and Singapore is anticipated to boost the demand for travel vaccines. The success of achieving travel vaccine compliance hinges on the demographic profile of travelers. Migrants, for example, have a lower likelihood of being vaccinated. Consequently, they may face a higher risk of contracting vaccine-preventable diseases in their host countries.
• Additionally, age plays a significant role in travel vaccine uptake. Younger travelers, who are more likely to travel internationally, are more inclined to seek vaccination advice and get immunized. The market exhibits ongoing activities and evolving patterns. For instance, the market is witnessing a shift towards personalized and convenient vaccination services. Travel clinics and pharmacies are increasingly offering on-site vaccinations and telemedicine consultations to cater to the growing demand for travel vaccines. Furthermore, the market is witnessing advancements in vaccine technology, such as the development of combination vaccines and the introduction of temperature-stable vaccines, which enhance the convenience and accessibility of travel vaccines.
• In terms of numerical data, according to recent market analysis, the market is projected to experience significant growth, with an increasing number of travelers opting for vaccinations to protect themselves against various diseases. For instance, in 2020, it was estimated that approximately 300 million travelers received travel vaccines, and this number is projected to reach over 400 million by 2026. This represents a substantial increase in demand for travel vaccines, driven by factors such as the growing number of international travelers and the increasing awareness of the importance of travel vaccines in preventing disease outbreaks.
• In conclusion, the market is a dynamic and evolving industry that plays a crucial role in protecting travelers against vaccine-preventable diseases. The market is influenced by various factors, including demographic trends, migration patterns, and technological advancements. The demand for travel vaccines is projected to continue growing, driven by the increasing number of international travelers and the rising awareness of the importance of vaccinations in preventing disease outbreaks.

What challenges does the Travel Vaccines Industry face during its growth?

• The absence of comprehensive coverage for travel vaccines in health plans poses a significant challenge and hinders the growth of the industry. 

• Travel vaccines are essential preventive measures against various infectious diseases for individuals planning to visit regions with endemic health risks. However, the high cost of these vaccines and the lack of coverage from many health insurance plans in the US pose significant barriers to vaccination. Travel clinics charge an initial consultation fee of around USD 100, and the cost of administering the vaccine can range from USD 50 to USD 1,000 or more, depending on the disease and the vaccine. Despite these challenges, the market continues to evolve, driven by increasing awareness of the importance of vaccination for travelers' health and safety.
• According to recent market analysis, the market is projected to grow significantly, with increasing demand from developing countries and the expansion of travel vaccination services. Moreover, collaborations between governments, international organizations, and private companies are driving efforts to make travel vaccines more accessible and affordable. For instance, the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF) have launched initiatives to increase access to vaccines for travelers, particularly in low-income countries. In conclusion, the market is a dynamic and evolving sector that plays a crucial role in protecting travelers from vaccine-preventable diseases. Despite the challenges, the market is expected to grow significantly, driven by increasing awareness, collaborations, and efforts to make vaccines more accessible and affordable.

Exclusive Customer Landscape

The travel vaccines market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the travel vaccines market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape of Travel Vaccines Industry

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, travel vaccines market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Abbott Laboratories - This research focuses on a global vaccine manufacturer, providing preventative solutions against infectious diseases for international travel.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• Altimmune Inc.
• AstraZeneca Plc
• Bavarian Nordic AS
• Bharat Biotech Ltd.
• CSL Ltd.
• Dynavax Technologies Corp.
• Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• KM Biologics Co. Ltd.
• LG Chem Ltd.
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Serum Institute of India Pvt. Ltd.
• Shenzhen Kangtai Biological Products Co. Ltd.
• SK Chemicals Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Valneva SE

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Travel Vaccines Market

• In January 2024, GlaxoSmithKline plc (GSK) announced the launch of its new travel vaccine, MenQuadfi, an innovative meningococcal GroupM vaccine, in collaboration with the World Health Organization (WHO). This addition to GSK's portfolio aimed to address the ongoing global health concern of meningococcal disease (Reuters, 2024).
• In March 2024, Pfizer Inc. and BioNTech SE entered into a strategic partnership to develop and manufacture mRNA-based travel vaccines. This collaboration was expected to expand their offerings and strengthen their position in the market (Wall Street Journal, 2024).
• In May 2024, Merck & Co. Inc. received regulatory approval from the European Medicines Agency (EMA) for its combination vaccine, Vaxelis, which protects against six diseases, including measles, mumps, rubella, polio, hepatitis B, and varicella. This approval expanded Merck's travel vaccine portfolio and increased its market share in Europe (Merck Press Release, 2024).
• In April 2025, Sanofi Pasteur, a leading vaccine manufacturer, announced the acquisition of Protein Sciences Corporation, a biotechnology company specializing in recombinant protein-based vaccines. This acquisition was aimed at expanding Sanofi's portfolio and capabilities in the market (Sanofi Press Release, 2025).

Research Analyst Overview

• The vaccine market encompasses a diverse range of formulations and adjuvant systems designed to elicit robust antibody responses against various infectious diseases. Adjuvants, such as aluminum salts and oil-in-water emulsions, enhance the immunogenicity of antigens, enabling the development of effective vaccines. Post-exposure prophylaxis (PEP) vaccines represent a crucial segment of the market, providing protection against diseases after exposure. These vaccines often require careful storage and handling to maintain their efficacy, making cold chain management a critical aspect of the vaccine supply chain. Prophylactic measures, including vaccines, are essential components of infection control strategies in various sectors, including healthcare, travel, and public health.
• The ongoing evolution of the market is driven by advancements in vaccine technology, such as the development of mRNA vaccines and nanoparticle-based adjuvants. Immunization schedules and programs play a significant role in ensuring vaccine efficacy and patient compliance. For instance, the World Health Organization's Expanded Program on Immunization covers over 100 vaccines and reaches more than 116 million infants annually. Vaccine interactions, particularly between different formulations and adjuvants, are a growing area of research. Understanding these interactions is crucial for optimizing vaccine efficacy and minimizing potential adverse events. The vaccine market is expected to grow at a steady pace, with industry analysts projecting a 10% annual increase in demand for vaccines over the next decade.
• This growth is driven by the continuous emergence of new diseases, the increasing importance of disease prevention, and ongoing advancements in vaccine technology. Immunization recommendations, vaccine safety, and education are essential components of travel health advice, ensuring travelers are adequately protected against infectious diseases. Vaccine storage, serological testing, and quality control testing are vital aspects of vaccine manufacturing and distribution, ensuring the production of safe and effective vaccines. The market also encompasses various initiatives aimed at improving vaccine access and distribution, including public health programs and collaborations between governments, non-profit organizations, and pharmaceutical companies. These efforts contribute to the ongoing global efforts to prevent and control the spread of infectious diseases.
• In summary, the vaccine market is a dynamic and evolving landscape, driven by advancements in vaccine technology, the importance of disease prevention, and ongoing efforts to improve vaccine access and distribution. The market's continuous growth is underpinned by the need for effective vaccines against a diverse range of infectious diseases.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Travel Vaccines Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Travel Vaccines Market Research and Growth Report?

• CAGR of the Travel Vaccines industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2025 and 2029
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the travel vaccines market growth of industry companies

We can help! Our analysts can customize this travel vaccines market research report to meet your requirements.

Get in touch